Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis
Authors
Keywords
-
Journal
Journal of Gastrointestinal Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-19
DOI
10.1007/s12029-022-00842-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MOOSE Reporting Guidelines for Meta-analyses of Observational Studies
- (2021) Benjamin S. Brooke et al. JAMA Surgery
- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
- (2020) Sangdeok Shin et al. MEDICINE
- Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
- (2020) Sudeep Tanwar et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019
- (2020) C. Bosetti et al. ANNALS OF ONCOLOGY
- Association of Daily Aspirin Therapy with Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis C Virus Infection
- (2020) Teng-Yu Lee et al. Clinical Gastroenterology and Hepatology
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- (2020) Tracey G. Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
- (2019) Teng-Yu Lee et al. JAMA Internal Medicine
- Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma
- (2019) Jiajia He et al. CANCER LETTERS
- Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
- (2019) Mohsen Malehmir et al. NATURE MEDICINE
- Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study
- (2019) Zhao-Qing Du et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants
- (2019) Shuijing Wang et al. PHARMACOLOGICAL RESEARCH
- Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
- (2018) Yan Qiao et al. BMC CANCER
- Aspirin induces Beclin-1-dependent autophagy of human hepatocellular carcinoma cell
- (2018) Zhenjun Huang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults
- (2018) In Cheol Hwang et al. Scientific Reports
- Long-term use of low-dose aspirin for cancer prevention: A 10-year population cohort study in Hong Kong
- (2018) Kelvin K.F. Tsoi et al. INTERNATIONAL JOURNAL OF CANCER
- Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
- (2018) Tracey G. Simon et al. JAMA Oncology
- Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
- (2017) Minjong Lee et al. HEPATOLOGY
- The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis
- (2017) Qing Pang et al. OncoTargets and Therapy
- Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway
- (2017) Shanshan S Wang et al. Cell Death & Disease
- NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project
- (2015) J. L. Petrick et al. Cancer Prevention Research
- Extrahepatic Platelet-Derived Growth Factor-β, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice
- (2014) Shuhei Yoshida et al. GASTROENTEROLOGY
- The mTOR pathway in hepatic malignancies
- (2013) Mamatha Bhat et al. HEPATOLOGY
- Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways
- (2011) Olorunseun O. Ogunwobi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Signalling pathways in alcohol-induced liver inflammation
- (2009) Pranoti Mandrekar et al. JOURNAL OF HEPATOLOGY
- Review article: blood platelet number and function in chronic liver disease and cirrhosis
- (2008) P. WITTERS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started